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Wilson disease (WD) is an autosomal recessive genetic disorder of copper metabolism, characterized by liver disease and neurological symptoms with accumulation 
of excess copper in liver, brain, and other tissues [1]. The 
worldwide prevalence of WD is estimated to be 1 in 30,000 live 
births, a gene frequency of 0.58%, and a carrier frequency of 1 
in 86 [2]. It is caused by mutation in the ATP7B gene encoding 
a copper transporter P-type ATPase, which results in decreased 
biliary copper excretion and diffuse accumulation of copper in 
liver. With increasing copper overload overtime, deposition of 
copper occurs in other organs such as nervous system, cornea, 
kidneys, and heart [3].
The clinical presentation of WD varies widely, a typically 
hepatic form which presents in the first decade of life is followed 
by neurologic symptoms and psychiatric symptoms which 
usually presents after the age of 20 years. Kayser–Fleisher (KF) 
ring is a brownish discoloration of outer margin of cornea due to 
deposition of copper in Descemet’s membrane. KF ring is present 
in 95% of patients with neurological symptoms, in 50%–60% 
of patients without neurological symptoms. WD can present as 
Coomb’s negative hemolytic anemia due to the release of large 
amounts of copper from damaged hepatocytes [4,5].
Laboratory parameters such as low ceruloplasmin and 
elevated 24-h urine copper and observation of KF rings in an 
ophthalmological examination carried out in combination direct 
toward the diagnosis [3]. Due to the lack of a single diagnostic 
test with adequate sensitivity, diagnosis should be based on 
the combination of clinical features, laboratory findings, and 
the results of mutation analysis in a patient with liver and/or 
neuropsychiatric manifestations [2].
Considering the rarity of disease, diagnosis has a great impact 
because a specific treatment of proven efficacy exists, and without 
timely management, the disease is in variably fatal. Limited studies 
are available that have described exclu sively pediatric samples 
and those that have been published generally have small patient 
samples [6-9]. Hence, this study was undertaken to study the 
clinical, biochemical, and histological profile of WD in children 
between 1 and 12 years of age in our geographical area.
ABSTRACT
Background: Wilson disease (WD) is a rare autosomal recessive disorder characterized by the accumulation of copper in the 
liver, brain, cornea, and kidneys. Asymptomatic nature of disease at earlier stages leads to diagnostic enigma. Objective: The 
objective of this study was to study the clinical, biochemical, and histological profile of WD in children between 1 and 12 years 
of age. Methodology: It was a hospital-based descriptive study. All children between 1 and 12 years of age who were admitted 
with symptoms of liver disease and neuropsychiatric symptoms were screened for WD. Low serum ceruloplasmin (<20 mg/dl) and 
presence of Kayser–Fleischer rings in cornea were the parameters for diagnosis of WD in the study. Clinical and laboratory data 
were collected from 32 children diagnosed with WD. Evaluation included detailed history and physical examination, ultrasound 
abdomen, upper endoscopy, laboratory examination, and liver biopsy. Results: The mean age of presentation was 9.2 years. Hepatic 
manifestations (53%) were the main presentation followed by neurologic (25%) and hepatocerebral (18.7%) manifestations. 
Predominant symptom was jaundice in 64.7% of children with hepatic manifestations. Speech disturbance was found to be the 
most common symptom in neurologic presentation. Ultrasound abdomen showed features of portal hypertension in 11 (34.7%) 
children. Different grades of esophageal varices were noted in 13 (40.5%) children. Histopathology of biopsied samples showed 
evidence of cirrhosis in 18 (56.2%) children and features of chronic active hepatitis in 14 (43.7%) children. Conclusion: Diagnosis 
of WD in children is obscure and this may invariably decelerate the diagnosis and prognosis of this malady. Therefore, children 
presenting with any form of liver disease and/or neuropsychiatric features, WD must be suspected and further investigations should 
be carried out.
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METHODOLOGY
A hospital-based descriptive study was conducted at a tertiary care 
teaching institute of Chennai for a period of 18 months. Ethical 
clearance was obtained from the institutional ethical committee 
and informed consent was taken from parents and children 
before recruitment. Children between 1 and 12 years of age, who 
presented with acute and chronic liver disease, extrapyramidal 
symptoms, speech disturbance, and gait disturbances, recent 
deterioration of school performance, and siblings of proven cases 
of WD, were subjected to preliminary screening. Children in 
whom liver biopsy was contraindicated were excluded from the 
study.
Indicators such as slit-lamp examination for KF ring and 
serum ceruloplasmin level were assessed in all the patients. 
Patients with serum ceruloplasmin level <20 mg/dl and positive 
KF ring were diagnosed as WD. A total of 32 children diagnosed 
with WD were included in the study. Detailed medical and family 
history was taken. Thorough physical examination was conducted 
to assess the presence of jaundice, hepatosplenomegaly, ascites, 
and signs of liver failure. Neurologic and psychiatric assessments 
were done. Investigations such as complete blood count, liver 
function tests, renal function test, ultrasound abdomen, upper 
gastrointestinal (GI) endoscopy, and liver biopsy were performed. 
RESULTS
The data obtained were tabulated and subjected to statistical 
analysis. Descriptive analysis was carried out to measure mean, 
standard deviation, and frequencies of the sample. A total of 32 
children aged 1–12 years, diagnosed with WD, were included in 
the study. Of 32 children, 18 (56.2%) belonged to the age group of 
10–12 years and only 2 (6.2%) children belonged to the age group 
of 3–5 years. The male-to-female ratio in the study population 
was 1.9:1 (Table 1). 
A total of 7 of 32 children had family history suggestive of WD. 
Consanguinity of parents was found in 9 (28.1%) cases, of which 
four children were born to the 2nd degree consanguineous parents 
and five children were born to the 3rd degree consanguineous 
parents. Of 32 patients, 20 (62.5%) resided in rural and 12 
(37.5%) resided in urban areas.
Hepatic presentations were noted in 17 (53.1%) of children, of 
which 8 (47%) belonged to the age group of 6–9 years followed 
by 7 (41.1%) in 10–12 years and 2 (11.7%) in 3–5 years of age. 
Among the 8 (25%) children who presented with neurological 
symptoms, 6 (75%) belonged to the age group of 10–12 years and 
2 (25%) in the age group of 6–9 years. Hepatocerebral presentation 
was noted in 6 (18.7%) of children, of which 4 (66.6%) belonged 
to the age group of 10–12 years and 2 (33.3%) were in the age 
group of 6–9 years. One (3.1%) patient who belonged to the age 
group of 6–9 years presented with Coomb’s negative hemolytic 
anemia (Table 2).
Of 17 children with hepatic manifestations, 2 (11.7%) 
children were asymptomatic, 4 (23.5%) children were initially 
diagnosed as acute hepatitis, and 11 (64.7%) children as chronic 
liver disease. Jaundice was the predominant symptom seen in 
12 (70.5%) children, followed by abdominal distension in 10 
(58.8%), fever in 7 (41.1%), and GI bleed in 3 (17.6%) patients. 
Of eight cases with neurological presentation, speech disturbance 
was the most common symptom seen in 6 (75%) children followed 
by gait disturbance in 5 (62.5%), involuntary movements in 4 
(50%), poor scholastic performance in 3 (37.5%), and behavioral 
disturbances in 3 (37.5%) children. 
Among six children with hepatocerebral presentation, speech 
disturbance was predominant symptom, seen in 4 (66.6%) 
children followed by gait disturbance in 3 (50%) children (Fig. 1).
Among the 17 children with hepatic presentation, jaundice 
12 (70.5%) was the predominant sign, followed by ascites in 
10 (58.8%), hepatosplenomegaly in 9 (52.9%), and anemia in 
4 (23.5%) children. Isolated hepatomegaly and splenomegaly 
were seen in 2 (11.7%) children each. Among eight children 
with neurological presentation, dysarthria was the predominant 
sign in 6 (75%) children, followed by dystonia in 5 (62.5%) 
children, tremors in 4 (50%) children, while 2 (25%) presented 
with chorea. Of six children with hepatocerebral presentation, 4 
(66.6%) children presented with jaundice, ascites, anemia, and 
isolated hepatomegaly and isolated splenomegaly in 1 (16.6%) 
child each (Fig. 2).
Fig. 1: Symptoms of Wilson disease in different presentations
Fig. 2: Signs in Wilson disease with different presentations
Table 1: Age and sex distribution of children with Wilson disease
Age group (years) Male n (%) Female n (%) Total n (%)
1–2 0 0 0
3–5 1 (50) 1 (50) 2 (6.2)
6–9 9 (75) 3 (25) 12 (37.5)
10–12 11 (61.1) 7 (38.8) 18 (56.2)
Total 21 (65.6) 11 (34.4) 32 (100)
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Liver function tests showed elevated serum glutamic 
oxaloacetic transaminase and serum glutamic pyruvic 
transaminase in 18 (56.2%) children, elevated serum bilirubin in 
14 (43.7%) children, and prolonged prothrombin time in 4 (12.5%) 
children. Ultrasound abdomen showed portal hypertension in 11 
(34.7%) children. Upper GI endoscopy showed different grades of 
esophageal varices in 13 (40.5%) children. Liver biopsy showed 
the evidence of cirrhosis in 18 (56.2%) children and features of 
chronic active hepatitis in 14 (43.7%) children.
DISCUSSION
Wilson’s disease is one of the rare forms of liver disease in 
children. The first possible case of WD was described by 
Frerichs (1861) in a 9-year-old boy with movement and speech 
abnormalities, whose autopsy showed liver cirrhosis [10]. In 
India, among pediatric liver diseases, WD accounts for 7.6–19.7% 
in tertiary hepatobiliary centers. Fifteen to 20 new cases of WD 
are registered annually in referral neurology centers [11]. There 
are few studies that have described exclusively pediatric samples 
and those that have been published generally have small patient 
samples [6-9].
Important indicators of disease which help in diagnosis are 
the presence of KF rings, low serum ceruloplasmin, and increased 
24 h urinary excretion. In our study, two parameters –positive KF 
ring and serum ceruloplasmin level <20 mg/dl were considered 
while screening of patients for WD [3].
A total of 32 children diagnosed with WD were included 
in our study. Majority of the children (56.2%) belonged to the 
age group of 10–12 years and only 6.2% of patients belonged 
to the age group of 3–5 years. The mean age of presentation in 
our study group was 9.2 years. Similar results were also noted in 
studies by Sánchez-Albisua et al. [12] (mean age=9.8±3.4 years), 
Yüce et al. [7] (10.1±2.5 years), and Kalra et al. [13] (7.2 years). 
The mean age of the onset of WD was 11.2 years and 12 years, 
respectively, in studies done by On et al., [14] and Saito [15] 
WD is asymptomatic in initial phases mainly due to ignorance of 
people; rarely, patients less than years are diagnosed; however, 
screening for the disease among the family members of patients 
may reduce this age by identifying asymptomatic patients earlier 
in life.
The male children predominated in our study with male-
female ratio of 1.9:1 which was similar to a study done by 
Adhami and Cullufi, [16] and other studies documented in the 
Indian literature [17]. This could be due to society norm which 
pays higher attention to male children, which invariably increases 
the visits to hospital. In our study, the majority of our children 
were from rural areas. In contrary, Bhave et al. [18] noted in their 
study that 72.2% of children were from urban areas. As reported 
by Panagariya et al., [19] unrecognized environmental factors or 
habit of cooking food in copper utensils (in 40% of their cases) 
could have implicated the triggering events for the illness.
History of consanguinity was found in 28.1% of children. 
In other studies, it has been found consanguinity in 25.8% and 
16.6% [18] of studied population, respectively, and mostly seen 
in Southern Indian population [20]. In our study, we noted family 
history suggestive of WD in 7 (21.8%) children. Similarly, 
positive family history has been documented by other previous 
studies [7,13,18]. This correlation helps to confirm the genetic 
nature of disease.
Among the many clinical presentations, hepatic form was most 
prevalent (53.2%) followed by neurologic presentation (25%) 
and hepatocerebral presentation (18.7%) and only 1 (3.1%) child 
presented with Coomb’s negative hemolytic anemia. Similar records 
from the literature show, hepatic presentations as the most prevalent 
form in WD [18,21], except in one study by Kalra et al. [13] which 
showed predominance of hepatocerebal presentation.
Jaundice (70.5%) was the most common symptom among the 
hepatic form, followed by abdominal distension (58.2%), pain 
abdomen (47%), lethargy and anorexia (41.1%), fever (41.1%), 
GI bleed (17.6%), and history of jaundice in 11.7%. Similarly, 
jaundice was the predominant symptom noticed in studies done 
by Saito, [15] and Kalra et al., [13] whereas, abdominal pain 
(76.9%) was the predominant symptom in a study conducted by 
Yuce et al. [7].
The earliest symptoms of neurologic and hepatocerebral 
disturbances are speech disturbance, gait disturbances, 
involuntary movements, personality change, and scholastic 
backwardness [13,22]. In the present study, speech disturbances 
(71.4%) and gait disturbances (57.1%) were the predominant 
symptoms followed by involuntary movements (35.7%). 
Hepatocerebral presentation includes hepatosplenomegaly, 
ascites, and icterus, as the most common signs. In the present 
study, in children with hepatic and hepatocerebral presentation, 
hepatosplenomegaly was the predominant sign (56.5%), followed 
by ascites (47.8%), isolated hepatomegaly (13%), and isolated 
splenomegaly (13%). Our study correlated with previous literature 
studies [7,23].
In our study, liver enzymes were elevated in 56.2% of 
children. Hypoalbuminemia was seen in 28.1% of children and 
prolonged prothrombin time in 12.5% of children. Ultrasound 
abdomen showed features of portal hypertension in 34.3% of 
cases. UGI endoscopy showed various grades of varices in 40.6% 
of children. Yuce et al. [7] in their study, found elevated liver 
enzymes in 42.3% of cases and hypoalbuminemia in 38.5% of 
cases. Adhami et al. [16] in their study, found portal hypertension 
Table 2: Age distribution among children with different presentations
Age (years) Hepatic (%) n=17 Neurological (%) n=8 Hepatocerebral (%) n=6 Others (%) n=1
3–5 2 (11.8) 0 0 0
6–9 8 (47) 2 (25) 2 (33.3) 1 (100)
10–12 7 (41.1) 6 (75) 4 (66.6) 0
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in 42.5% of children. In our study, histopathologic evaluation of 
biopsy samples showed features of cirrhosis in 56.2% of children 
and chronic active hepatitis in 43.7% of children. This was similar 
to the study by Park et al. [24] (56%).
The results of the present study emphasize the importance 
of screening the patients with liver and/or neuropsychiatric 
symptoms and carrying out specific tests to increase the sensitivity 
of diagnosis of suspected cases. Limitations include small sample 
size and short duration of study which avert us from generalizing 
the results. We further recommend conducting a study in larger 
population, in a multi-institution setup which will help us to 
draw conclusions. Further, assessment of genetic and molecular 
changes will definitely aid in confirmation of the disease.
CONCLUSION
WD is a rare disease and diagnosis is a challenge for pediatricians 
and hepatologists since it can present in an oligosymptomatic form 
and test results may show little abnormalities. Although diagnosis 
depends on observing the clinical and laboratory data that provide 
evidence of abnormal copper metabolism, no single parameter is 
trustworthy in isolation. However, many pediatric patients do not 
exhibit all three. Therefore, maintaining a high index of suspicion, 
disease should always be considered in a patient of any age who 
exhibits hepatic and/or neurological abnormalities.
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